.
MergerLinks Header Logo

New Deal


Announced

EQT-backed Waystar to acquire Patientco from Accel-KKR and The Blue Venture Fund for c.$450m.

Financials

Edit Data
Transaction Value£324m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Domestic

United States

Majority

omnichannel patient payments

Private

Payments / Commerce

Friendly

Acquisition

Single Bidder

Pending

Private Equity

Synopsis

Edit

EQT-backed Waystar, a healthcare payments software provider, agreed to acquire Patientco, a provider of omnichannel patient payments, communications and engagement software, from Accel-KKR and The Blue Venture Fund for c.$450m. The combination is subject to regulatory approval and customary closing conditions. "Patients are more responsible for their healthcare expenses than ever before, and they expect modern, consumer-friendly interactions from healthcare providers and insurers. Together, we will further simplify how patients engage with healthcare providers and provide transparency, empowerment and ease of use that needed to plan and pay for healthcare. Providers will benefit from increased patient satisfaction and fuller reimbursement," Matthew Hawkins, Waystar CEO and Board Member.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US